. The present study was performed to compare hs-CRP and LDL-C in association with the cardio-ankle vascular index (CAVI) in Japanese community dwellers considered to be at low risk for atherosclerosis from their level of traditional CVD risk factors. Methods: A community-based study involving 386 healthy Japanese (261 men and 125 women) without a history of CVD and medications for hypertension, diabetes, and dyslipidemia was performed. Multiple adjustments were performed with linear regression models to estimate the association between CAVI and hs-CRP or LDL-C levels. The participants were divided into four groups on the basis of whether they were above or below the median hs-CRP and LDL-C values, and CAVI was compared among the four groups by analysis of covariance after adjusting for confounders. Results: In multiple linear regression models, hs-CRP showed a significant positive association with CAVI; however, no clear association was observed between CAVI and LDL-C. These results were similar in the analyses among the participants with LDL-C ＜140 mg/dL or hs-CRP ＜1.0 mg/L. CAVI was higher in the groups with high hs-CRP than in those with low hs-CRP, irrespective of LDL-C; however, CAVI was highest in the group with high LDL-C and high hs-CRP. Conclusions: The present study suggests that hs-CRP could be a better risk factor assessor for atherosclerosis than LDL-C in individuals considered to be at low risk for atherosclerosis assessed by their traditional CVD risk factors.
Introduction
Both low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hs-CRP) are associated with an increased risk for cardiovascular disease (CVD) [1] [2] [3] [4] ; however, in the Women's Health Study, almost half of the CVD events occurred in par-cancer. The participants were recruited by Kobe municipal government, such as on websites and in magazines, or by advertising in newspapers and by posters or leaflets in public facilities, universities, and companies in Kobe city. Written informed consent was obtained from each participant. As part of the baseline survey of this cohort study, CAVI was performed in 403 individuals from July 2010 to October 2011. Of these, 17 participants were excluded because of the following reasons: did not meet the study criteria (n = 12); triglyceride ≥ 400 mg/dL (n = 1); and hs-CRP ＞10.0 mg/L (n = 4). The remaining 386 individuals (261 men and 125 women) were included in the present study.
The present study was approved by the Ethics Committee of the Institute of Biomedical Research and Innovation.
Data Collection and Standardization
Height and weight were measured while wearing socks and light clothing, and body mass index (BMI) was calculated as weight (kg) divided by height squared (m 2 ). The participants were asked to respond to questionnaires about lifestyle-related factors, such as medication, smoking (current smoker or not), and alcohol consumption (current drinker or not).
Fasting blood samples (after fasting for at least 10 h) were obtained from all participants, and blood samples were tested by one commissioned clinical laboratory center (SRL Inc., Tokyo, Japan). Plasma glucose, serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglyceride levels were measured by enzymatic methods. Then, LDL-C was calculated by Friedewald's formula. Serum hs-CRP was measured using a BN II nephelometer (Dade Behring, Deerfield, IL, USA).
CAVI was measured using a VaSera CAVI instrument (Fukuda Denshi Co. Ltd., Tokyo, Japan). Briefly, cuffs were applied to the bilateral upper arms and ankles with the participant lying in the supine position. After a 5-min rest, the examination was performed. CAVI was calculated by the following formula:
where Ps is systolic blood pressure, Pd is diastolic blood pressure, PWV is pulse wave velocity, ΔP is Ps− Pd, ρ is blood density, and a and b are constants. Scale conversion was performed to compare CAVI with PWV (Hasegawa's method). The VaSera is equipped with both measurement and calculation systems and automatically calculated CAVI. ticipants with LDL-C ＜130 mg/dL, and hs-CRP identified at-risk individuals with low LDL-C levels 5) . Furthermore, a large-scale, randomized, clinical trial (JUPITER) reported that lipid-lowering therapy reduced incident CVD in individuals with elevated hs-CRP who did not meet the criteria for lipid-lowering drug therapy 6) . Thus, hs-CRP could be a useful adjuvant guide for therapy to complement established traditional risk factors such as dyslipidemia 7) . Compared to the Western population, the Japanese have been reported to have lower cholesterol levels 8) . Moreover, CRP has been reported to be much lower in the general population without a history of CVD in Japan than in Western countries 9, 10) . Thus, whether such a low CRP level is still associated with atherosclerosis in the Japanese general population with low LDL-C should be investigated.
The cardio-ankle vascular index (CAVI) is a novel arterial-stiffness parameter 11, 12) . The CAVI has been demonstrated to be associated with CVD [13] [14] [15] , and it is considered to be a good marker of atherosclerosis 16) . Thus, a cross-sectional study, involving 386 Japanese individuals without a past history of CVD and who were free from medication for hypertension, diabetes, and dyslipidemia, was conducted to investigate the relationships among LDL-C, hs-CRP, and CAVI in a general population that was considered to be at low risk for CVD.
Aim
The aim of the present study was to compare hs-CRP and LDL-C levels in association with the CAVI in Japanese community dwellers considered to be at low risk for atherosclerosis from their level of traditional cardiovascular (CVD) risk factors.
Methods

Study Participants
Data from the baseline survey in the Kobe Orthopedic and Biomedical Epidemiological study (KOBE study) were analyzed. The KOBE study is a population-based cohort study in which the endpoint is considered worsening of quality of life or CVD risk factors, such as hypertension, diabetes mellitus, and dyslipidemia. Study participants were volunteers aged 40 to 74 years who were residents of Kobe city, one of the major urban areas in Japan. The participants had to meet the following criteria: 1) not currently on medications for hypertension, dyslipidemia, and diabetes mellitus; and 2) no past history of CVD and Table 1 shows the sex-specific characteristics of the participants. The mean age was 61±9 years in men and 63±8 years in women. The mean LDL-C in women was higher than the normal limit, but they did not meet the criteria for lipid-lowering drug therapy 17) . The mean blood pressure and glucose level did not meet the criteria for hypertension or diabetes mellitus 18, 19) . The associations between CAVI and hs-CRP (log-transformed) or LDL-C in multiple linear regression models are presented in Table 2 (sex-specific) and Table 3 (sex-combined). In all models, hs-CRP showed a significant positive association with CAVI. In women, the standardized coefficient of hs-CRP was the second largest next to age in Model 2. On the other hand, no clear association was observed between CAVI and LDL-C. Adding uric acid, smoking (current or non-current), and alcohol drinking (current or non-current) as independent variables, or substituting waist circumference for BMI in Model 2 did not change these results (data not shown). In sex-combined analyses, the same analyses were performed in the participants with LDL-C ＜140 mg/dL (n = 253) and in those with hs-CRP ＜1.0 mg/L (n = 347); the results were similar (data not shown). Table 4 shows the associations between CAVI and the four groups classified by combinations of LDL-C and hs-CRP. CAVI was higher in the groups with high hs-CRP than in those with low hs-CRP, irrespective of LDL-C levels. CAVI was highest in the participants with high hs-CRP and high LDL-C, and
Statistical Analysis
Sex-specific and sex-combined analyses were performed. Multiple adjustments were performed with linear regression models to estimate the association between CAVI and hs-CRP (log-transformed) or LDL-C level. Model 1 included sex, age, LDL-C, and hs-CRP, and Model 2 included the variables in Model 1 plus systolic blood pressure, heart rate, BMI, HDL-C, and fasting glucose. The adjusted coefficient of determination (adjusted R 2 ) was also calculated. Furthermore, the participants were divided into four groups classified by the combination of the medians for LDL-C and hs-CRP. Then, CAVI was compared among the four groups by analysis of covariance (ANCOVA) after adjustment for age, sex, systolic blood pressure, heart rate, HDL-C, fasting glucose, BMI, smoking, and alcohol drinking to investigate the relationships between CAVI and the combinations of LDL-C and hs-CRP.
All p values were two-tailed and the significance level was set at p＜0.05. The statistical package SPSS 15.0J for Windows (SPSS, Tokyo, Japan) was used to perform these analyses.
Results
The mean age of the participants was 62±9 years, the mean LDL-C was 129±29 mg/dL, and the median hs-CRP was 0.26 (0.05-5.38) mg/L. The geometric mean hs-CRP was 0.28 mg/L. The mean CAVI was 8.1±1.0. incident CVD in individuals with elevated hs-CRP levels who did not meet the criteria for lipid-lowering drug therapy 6) . From these results, individuals with high LDL-C are naturally considered to be at high risk for atherosclerosis; however, CRP is a candidate adjuvant guide for the risk assessment of future atherosclerosis or therapy in individuals without established traditional risk factors such as dyslipidemia [5] [6] [7] . Thus, the present study was performed to investigate whether CRP could identify individuals at high risk for atherosclerosis in comparison with LDL-C in participants who were considered to be at low risk from their traditional CVD risk factors including LDL-C. The participants in the Women's Health Study were naturally considered to be at low risk for CVD because their LDL-C was ＜130 mg/dL; however, the participants in the present study might be even healthier than those in the previous study. Not only the mean LDL-C level in both sexes combined (129 mg/dL), but also the mean blood pressure and glucose levels in both men and women were considered to be within normal levels in the present study, and BMI and hs-CRP levels were higher in the previous study. In addition, the very low prevalence of smoking was one of lowest in those with low hs-CRP and low LDL-C. In sex-combined analyses, the relationships between the four groups and multivariate-adjusted CAVI were significant. The results were similar when the same analyses were performed in sex-combined participants with CRP ＜1.0 mg/L (n = 347) (data not shown).
Discussion
In the present study, hs-CRP showed a significant positive association with CAVI; on the other hand, no clear association between LDL-C and CAVI was observed. However, when CAVI was compared among the four groups divided by the combination of LDL-C and hs-CRP, the participants with high-LDL and high hs-CRP showed the highest CAVI among the four groups.
Both LDL-C and hs-CRP are associated with an increased risk for CVD [1] [2] [3] [4] ; however, in the Women's Health Study, almost half of the CVD events occurred in participants with LDL-C ＜130 mg/dL, and hs-CRP identified at-risk individuals with low LDL-C levels 5) . A large-scale, randomized, clinical trial (JUPI-TER) reported that lipid-lowering therapy reduced gests that CRP ＞10.0 mg/L might indicate the need to consider an ongoing infectious or inflammatory disease 21) . Accordingly, the data were analyzed after the exclusion of participants with CRP ≥ 10 mg/L. In addition, the same analyses were performed in participants with CRP ＜1.0 mg/L, who were considered to be in a low-risk category for coronary artery disease according to the recommendation by the AHA/ CDC 21) . In these analyses, the results were similar to those in overall participants. Thus, low hs-CRP might be associated with atherosclerosis, and hs-CRP screening could be useful to predict future CVD events from the early stage of atherosclerosis, especially in individuals without traditional CVD risk factors.
For LDL-C, a previous study also showed no clear association between LDL-C and CAVI in a relatively healthy general rural population without a history of CVD 14) ; however, Miyashita et al. reported that ezetimibe improved CAVI in addition to lowering LDL-C in type 2 diabetic patients, and the patients with a high response to ezetimibe followed by achievement of the goal of LDL-C ＜120 mg/dL showed significant improvement of CAVI 22) . They concluded the characteristics of the present study (men 10.7%, women 1.6%). Although the present study was crosssectional in design and the independent variable was CAVI and not CVD events, the hs-CRP showed a stronger association with CAVI than LDL-C.
The strength of the present study was that the participants were a general population without a history of CVD and on no medication for hypertension, diabetes, and dyslipidemia. Because healthy community dwellers seldom visit hospitals to undergo examinations for atherosclerosis, it is usually difficult to collect data about the parameters for atherosclerosis in relatively healthy individuals compared to patients. Occupational health data could be a candidate to investigate the present study question, but it might be difficult to assess the participants' atherosclerosis condition because of the healthy worker effect 20) or younger age compared to the general population.
One of the problems of using hs-CRP as a risk factor for atherosclerosis might be that hs-CRP could increase in various conditions other than atherosclerosis. The American Heart Association and the Centers for Disease Control (AHA/CDC) position paper sug- oxysterol, which is highly toxic and enhances inflammation, followed by the onset of atherosclerosis; therefore, CAVI may increase under certain conditions in dyslipidemia 12) . Thus, hs-CRP might be a marker of inflammation due to oxidative stress, and an association between hs-CRP and arterial wall stiffness might be observed in the present study. Thus, the association between LDL-C and CAVI including hs-CRP remains a future topic to be investigated, especially in further combination with apolipoprotein B14 or oxidized LDL-C 23) . The present study had several limitations. First, because it was a cross-sectional study, causality could not be determined, and the results should be confirmed by future prospective studies. Second, hs-CRP elevation might have been caused by diseases other than atherosclerosis, of which the participant was unaware. Third, because the participants in the present study were considered to be volunteers with high health consciousness, application of the results in the present study to the general population should be carefully considered. Fourth, because CAVI is still a new device for the assessment of atherosclerosis and that diabetic patients had shown high cholesterol absorption and that ezetimibe might have the potential to ameliorate vascular stiffness through the inhibition of cholesterol absorption 22) . Furthermore, Miyoshi et al. have reported that CAVI was independently associated with LDL-C in multivariate analysis among individuals with significant coronary stenosis, defined as 50% or greater luminal diameter narrowing assessed by coronary angiography 15) . Thus, the relationship between CAVI and LDL-C may be different among high-risk participants, including patients with diabetes or coronary artery disease, and low-risk participants. In addition, in the present study, a tendency toward a positive association between LDL-C and CAVI was observed in women when the relationship between CAVI and the tertile of LDL-C was evaluated, although the relationship was not significant (data not shown). Moreover, CAVI was highest in participants with high hs-CRP and high LDL-C among the four groups in the present study. According to Shirai et al., hyperlipidemia per se does not immediately increase arterial wall stiffness 12) . After the accumulation of cholesterol in the lipid pool, oxidative stress generates : adjusted for age, systolic blood pressure, heart rate, fasting glucose, BMI, HDL-C, smoking (current or non-current), and alcohol drinking (current or non-current). Multivariate-adjusted mean † : adjusted for sex in addition to variables adjusted in the above model ＊ . the relationship with future CVD events has not been sufficiently investigated in a prospective study, it is unconfirmed that the relationships among hs-CRP, LDL-C and CAVI reflect those among hs-CRP, LDL-C and future CVD events in a healthy general population.
Conclusions
In the cross-sectional study performed in an urban Japanese general population who were considered to be at low risk for atherosclerosis without medication for hypertension, diabetes, and dyslipidemia, hs-CRP was positively associated with CAVI; however, no clear association between LDL-C and CAVI was observed. Thus, the present study indicates that hs-CRP could be a better risk factor for atherosclerosis than LDL-C in individuals who seem to be at low risk when assessed by established traditional CVD risk factors.
